Press Releases

Recent & Archived News

July 18, 2019

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer

Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ('Ono') announced today the three companies have entered into a clinical collaboration agreement to evaluate the...

Learn more
July 17, 2019

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer

Pyxis Oncology ('Pyxis'), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the...

Learn more
July 15, 2019

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to assess myocardial perfusion...

Learn more
July 01, 2019

Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform

Century Therapeutics, a Versant Ventures-created company developing allogeneic or off-the-shelf immune cell therapies for cancer, emerged from stealth mode today with USD 250 million in financing...

Learn more
June 26, 2019

Bayer to present new data from its hemophilia A portfolio at the International Society of Thrombosis and Haemostasis (ISTH) 2019 annual congress

Bayer will present new data highlighting clinical outcomes from its hemophilia A portfolio, which include long-term data from the PROTECT VIII investigational study evaluating use of Jivi®...

Learn more
June 25, 2019

California PCA Wins Polaris Ranger® in Velum® One Sweepstakes

Nicholas Carrico of Butte Valley, California, won a Polaris Ranger® 570 in the Bayer Velum® One Nematode Ranger Sweepstakes. Growers, pest control advisors (PCAs) and consultants could enter the...

Learn more
June 19, 2019

Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer

Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with...

Learn more
June 19, 2019

Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science

The Environmental Science business of Bayer is honored to have contributed $45,000 toward the development of the new Cook Museum of Natural Science that opened on June 7 in Decatur, AL. The museum...

Learn more
June 17, 2019

Bayer Launches Blue Ribbon Beekeepers, Announces Feed a Bee Grants to Celebrate National Pollinator Week

The Bayer Bee Care Program is celebrating National Pollinator Week by honoring those who are working hard to support bees and other pollinators around the country. The company announced Blue...

Learn more
June 11, 2019

Bayer Donates $50,000 to the Association of Foreign Correspondents in the United States

Bayer announces today its new partnership with the newly formed Association of Foreign Correspondents in the United States (AFC) that will provide present and future generations of journalists the...

Learn more

 

Want even more Bayer news?

Check out our Social Media & Blogs.